[Properties of (Ala5, Orn9)-somatostatin. The inhibition of pancreatic and hypophyseal hormone secretion in cell culture].
Ability of Ala5, Orn9-somatostatin to inhibit the secretion of insulin, glucagon, somatotropic hormone (STH) and prolactin was tested on the model of primary monolayer culture of isolated insular pancreatic and adenohypophyseal cells. Chemical substitution performed between positions 5 and 9 in somatostatin molecule failed to change essentially hormone's biologic activity in suppression of insulin and glucagon in the culture of pancreatic insular cells isolated from newborn rats. Somatostatin analog revealed its natural hormonal ability to inhibit STH secretion but failed to affect that of prolactin. The results are suggestive of the principal possibility to produce somatostatin biologically active analog through lyzine residue substitution in position 9 with obligatory simultaneous substitution amino acid residue in position 5.
D000818:Animals; D002478:Cells, Cultured; D008297:Male; D010187:Pancreatic Hormones / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010907:Pituitary Hormones / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013997:Time Factors
D010187:Pancreatic Hormones; D010907:Pituitary Hormones; C049106:somatostatin, Ala(5)-Orn(9)-; D013004:Somatostatin
Izuchenie svoĭstv (Ala5, Orn9)-somatostatina. Ingibirovanie sekretsii pankreaticheskikh i gipofizarnykh gormonov v kul'ture kletok.